Table of Contents
Recently, Philippine actress Kris Aquino’s EGPA illness surfaced on social media. The actress was diagnosed with eosinophilic granulomatosis with polyangiitis or EGPA.
In her Instagram reel post, she shared her latest medical condition.
Maraming salamat po sa lahat ng nagdasal for my recovery. Here’s the TRUTH as explained by my attending physician Dr. Niño Gavino, an exceptional Filipino American doctor based in Houston who successfully diagnosed what’s really wrong with my health.
i’ll miss you- my friends & followers very much. Time is now my enemy, naghahabol kami hoping na wala pang permanent damage to the blood vessels leading to my heart.
so many people to thank but I choose to do that privately. #grateful
For now and the next few years- sadly, it’s goodbye. Praying na kayanin ng katawan ko itong matinding pagsubok.
kahit 17 hours away na kami nila kuya josh & bimb to fly to & the Pacific Ocean separates the 🇵🇭 from 🇺🇸, i’d still like to end this with #lovelovelove
View this post on Instagram
What is Eosinophilic Granulomatosis with Polyangiitis (EGPA)?
Kris Aquino’s EGPA disease is a rare, life-threatening disease that affects the lungs. It is caused by an overgrowth of eosinophils, a type of white blood cell. These cells are responsible for fighting infection, but in EGPA they become involved in the destruction of tissues in the lungs.
EGPA is most commonly diagnosed in adults over the age of 40, but it can occur at any age.
EGPA (also known as Churg-Strauss syndrome) typically starts with symptoms such as fever, chest pain, and shortness of breath. As the disease progresses, it can lead to widespread lung damage and even death. There is no known cure for EGPA according to the American Lung Association, but early diagnosis and treatment are essential for survival.
Eosinophilic granulomatosis with polyangiitis is often mistaken for other lung diseases because it causes similar symptoms. It is important to get evaluated by a doctor if you have any unexplained shortness of breath or persistent fever. Early diagnosis and treatment can save your life.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare autoimmune disease that affects the lungs. The disease is thought to be caused by an overactive immune system attacking the body’s blood vessels. EGPA is often fatal, although there is currently no cure. The majority of people who develop EGPA experience progressive lung damage and die from complications related to the disease. There is currently no effective treatment for EGPA, although researchers are working on developing new treatments that may improve patient outcomes.
Kris Aquino’s EGPA illness is a rare and severe type of granulomatosis that affects the blood vessels. It is caused by a reaction between the proteins eosinophil and angiogenin.
Is EGPA a Fatal Disease?
Kris Aquino’s EGPA condition is a rare and deadly disease. It is typically caused by an overactive immune system, which leads to the formation of large numbers of eosinophils, a type of white blood cell. These eosinophils can attack and damage the blood vessels in the body, leading to inflammation and often fatal infection. There is no known cure for EGPA, which means that it is usually fatal.
View this post on Instagram
What are the symptoms of EGPA?
Kris Aquino’s EGPA illness is a life-threatening disorder that results from the overproduction of eosinophils, a type of white blood cell. Eosinophils are responsible for the inflammation and destruction associated with this condition.
The most common symptoms of EGPA include fever, chest pain, shortness of breath, and swelling in the legs or lungs. In some cases, people also experience ear infections, heart problems, and damage to blood vessels in the brain or elsewhere in the body. Treatment typically involves aggressive therapy to suppress the eosinophil count and prevent further damage to organs.
What causes EGPA?
The cause of Kris Aquino’s EGPA is unknown, but EGPA is often associated with other autoimmune diseases, such as systemic lupus erythematosus (SLE), which can lead to the overproduction of other types of cells. EGPA can also be caused by infection or injury to the blood vessels. Treatment typically involves aggressive chemotherapy and/or surgery to remove affected organs.
How is Kris Aquino’s EGPA illness can be treated?
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, life-threatening condition that affects the lungs and blood vessels. EGPA is caused by a combination of genetic and environmental factors, including exposure to certain allergens.
Unfortunately, Kris Aquino’s EGPA disease is still in the stage of clinical studies and evaluation.
There is no known cure for Kris Aquino’s EGPA condition at the time of this article, but treatment focuses on relieving symptoms and preventing complications. Treatment usually involves aggressive therapy to control the inflammation and reduce the risk of recurrence. Patients may also require long-term follow-up to monitor for potential complications.
According to the Food and Drug Administration (FDA), Nucala is now approved for use in adults with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis, an inflammation in the wall of blood vessels of the body. This new indication provides patients with EGPA access to an FDA-approved therapy that may improve their quality of life.
What kind of doctor treats EGPA disease?
EGPA is a rare and serious autoimmune disease that affects the lungs, liver, and blood. Treatment typically includes lung surgery, chemotherapy, and immune therapy.
Most doctors who treat EGPA disease are specialists in rheumatology, oncology, or immunology. These doctors will work together to determine which treatments are best for you. If you have EGPA disease, it’s important to find a doctor who can help you manage your symptoms and improve your health overall.
View this post on Instagram
What is the prognosis for Kris Aquino’s EGPA disease?
The prognosis for Kris Aquino’s EGPA illness is generally poor, with a median survival time of just over one year. Many patients experience significant disability due to the disease, which can lead to respiratory failure and heart failure. There is no cure for EGPA, but treatment focuses on managing the symptoms and preventing complications.
How can EGPA be prevented?
Kris Aquino’s EGPA is caused by an overproduction of eosinophils, a type of white blood cell. Eosinophils are responsible for the inflammation and swelling that occurs in EGPA. The most common way to prevent EGPA is to prevent the overproduction of eosinophils. There are currently no known cures for Kris Aquino’s EGPA condition, but treatment options include chemotherapy, immunotherapy, and stem cell transplantation.
Conclusion: Kris Aquino’s EGPA medical condition
Kris Aquino’s EGPA disease is a rare and severe type of granulomatosis. It is caused by a reaction between the proteins eosinophil and angiogenin. The symptoms of EGPA vary but typically include fever, chest pain, and sudden onset of shortness of breath. Treatment typically requires long-term immunosuppressive therapy. The prognosis for EGPA is generally poor, but there are some cases that have responded well to treatment. EGPA can be prevented by identifying and treating any underlying causes.
- National Center for Advancing Translational Sciences – Eosinophilic granulomatosis with polyangiitis
- Mayo Clinic – Churg-Strauss syndrome
- FDA – FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
- American Lung Association – Treating and Managing EGPA
- Cleveland Clinic – EGPA (formerly Churg-Strauss Syndrome)
- Medscape – Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome) Treatment & Management
- WebMD – Treatment of Churg-Strauss Syndrome